Contract 75A50119C00075
Emergent Biosolutions Canada Inc · Department Of Health And Human Services · March 30, 2026
Emergent Biosolutions Canada Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on March 30, 2026 for $256.40 million (current value) of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $256.40 million.
Contract details
- PIID
- 75A50119C00075
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 30, 2026
Description
EO14042 BOTULISM ANTITOXIN
Modification timeline
-
March 30, 2026Mod P00014 · Change Order$256.40M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 27, 2026 | $176.14M |
| Bavarian Nordic, Inc. | Department Of Health And Human Services | March 27, 2026 | $127.5K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50119C00075?
Contract 75A50119C00075 is a federal contract awarded to Emergent Biosolutions Canada Inc by Department Of Health And Human Services on March 30, 2026 for $256.40 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50119C00075?
Emergent Biosolutions Canada Inc won contract 75A50119C00075 from Department Of Health And Human Services.
How much is contract 75A50119C00075 worth?
Contract 75A50119C00075 has obligated $0 to date but carries a potential ceiling of $256.40 million if fully funded and all options are exercised.